Release Date: March 10, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you speak to the visibility you have on closing the remaining deals that were expected to close at the end of 2024? A: Christopher Fowler, President and CEO, explained that while some deals have been delayed due to factors outside their control, such as administrative changes in state governments, they remain confident these deals will close in the first half of 2025.
Q: On the sales and marketing initiatives, do you expect those to increase in tandem with revenue increases? A: Christopher Fowler noted that they are making substantial investments, particularly in marketing, to increase brand exposure, especially among 100 to 400 bed hospitals. This is expected to lead to revenue expansion into 2026.
Q: Can you quantify the visibility you have into 2025 revenue guidance based on current bookings and pipeline? A: Christopher Fowler and Vinay Bassi, CFO, emphasized that the guidance reflects learnings from 2024 and a close alignment between operations, sales, and finance teams to accurately translate bookings into revenue.
Q: How should we think about growth among the two segments, Financial Health and Patient Care, for 2025? A: Vinay Bassi indicated that Financial Health is expected to have higher growth, while Patient Care is anticipated to see low single-digit growth, driven by new product offerings.
Q: Regarding the 60 renewals over the next 24 months, how does this compare to a typical year, and are there any outsized clients in this group? A: Christopher Fowler stated that the 60 renewals are spread over 24 months and do not include any outsized clients. The focus is on ensuring customer satisfaction and retention.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.